Novo Nordisk As Stock Price History

NVO Stock  USD 64.33  2.12  3.19%   
Below is the normalized historical share price chart for Novo Nordisk AS extending back to April 30, 1981. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novo Nordisk stands at 64.33, as last reported on the 1st of May, with the highest price reaching 64.33 and the lowest price hitting 64.33 during the day.
IPO Date
29th of September 2025
200 Day MA
103.082
50 Day MA
74.4024
Beta
0.247
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. Novo Nordisk AS has Sharpe Ratio of -0.0994, which conveys that the firm had a -0.0994 % return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Risk Adjusted Performance of (0.18), standard deviation of 3.06, and Mean Deviation of 2.39 to check out the risk estimate we provide.
At this time, Novo Nordisk's Total Stockholder Equity is very stable compared to the past year. As of the 1st of May 2025, Common Stock Shares Outstanding is likely to grow to about 4.8 B, though Other Stockholder Equity is likely to grow to (1.9 M). . At this time, Novo Nordisk's Price Fair Value is very stable compared to the past year. Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0994

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNVO

Estimated Market Risk

 3.13
  actual daily
27
73% of assets are more volatile

Expected Return

 -0.31
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.
Price Book
12.7274
Enterprise Value Ebitda
13.5951
Price Sales
0.9592
Shares Float
3.2 B
Dividend Share
11.4

Novo Nordisk Stock Price History Chart

There are several ways to analyze Novo Stock price data. The simplest method is using a basic Novo candlestick price chart, which shows Novo Nordisk price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 25, 202589.51
Lowest PriceApril 17, 202558.08

Novo Nordisk May 1, 2025 Stock Price Synopsis

Various analyses of Novo Nordisk's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novo Stock. It can be used to describe the percentage change in the price of Novo Nordisk from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novo Stock.
Novo Nordisk Price Rate Of Daily Change 0.97 
Novo Nordisk Price Action Indicator(1.06)

Novo Nordisk May 1, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Novo Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Novo Nordisk intraday prices and daily technical indicators to check the level of noise trading in Novo Stock and then apply it to test your longer-term investment strategies against Novo.

Novo Stock Price History Data

The price series of Novo Nordisk for the period between Fri, Jan 31, 2025 and Thu, May 1, 2025 has a statistical range of 31.43 with a coefficient of variation of 12.85. The daily prices for the period are spread out with arithmetic mean of 75.36. The median price for the last 90 days is 77.54. The company underwent 2:1 stock split on 22nd of October 2021. Novo Nordisk AS issued dividends to stockholders on 2025-03-31.
OpenHighLowCloseVolume
05/01/2025
 66.45  64.33  64.33  64.33 
04/30/2025
 66.47  66.64  65.40  66.45  9,221,701 
04/29/2025
 65.26  65.41  64.16  65.16  10,554,351 
04/28/2025
 62.19  63.25  61.97  62.62  6,280,300 
04/25/2025 60.67  62.27  60.57  62.08  7,526,649 
04/24/2025 62.48  62.74  61.84  62.63  7,511,749 
04/23/2025 61.77  62.43  60.89  61.30  8,951,943 
04/22/2025 59.01  60.17  58.92  59.91  11,516,450 
04/21/2025 58.25  59.30  57.00  58.33  13,048,471 
04/17/2025
 57.91  59.06  57.28  58.08  30,204,789 
04/16/2025
 64.33  64.41  62.40  62.88  6,011,954 
04/15/2025
 65.64  65.95  63.86  64.49  5,945,600 
04/14/2025
 66.48  66.75  65.33  66.06  7,855,272 
04/11/2025
 63.73  65.00  63.23  64.73  10,701,443 
04/10/2025
 63.12  63.24  59.32  61.21  9,930,221 
04/09/2025
 60.49  65.30  59.52  65.09  13,183,437 
04/08/2025
 64.92  65.05  60.83  61.60  8,100,500 
04/07/2025 61.44  65.28  60.61  63.64  14,258,090 
04/04/2025
 65.23  65.47  62.37  62.55  10,850,100 
04/03/2025
 68.43  68.54  67.00  67.10  8,802,328 
04/02/2025
 67.51  68.72  67.32  68.24  7,337,200 
04/01/2025
 69.98  70.00  67.64  68.03  5,957,353 
03/31/2025
 67.72  69.63  66.88  69.44  6,500,322 
03/28/2025
 69.06  69.23  68.08  68.20  5,859,400 
03/27/2025
 69.05  69.52  68.66  69.05  7,970,800 
03/26/2025
 71.41  71.70  70.46  70.59  7,582,300 
03/25/2025
 74.68  74.84  72.04  72.43  8,895,600 
03/24/2025
 73.78  74.79  73.71  74.14  8,083,200 
03/21/2025
 74.76  76.06  74.32  75.64  5,880,500 
03/20/2025
 77.96  78.30  77.25  77.54  4,572,500 
03/19/2025
 78.88  78.96  77.24  77.75  6,920,600 
03/18/2025
 80.91  81.26  78.94  79.70  5,696,400 
03/17/2025
 78.38  79.28  78.09  78.88  5,995,800 
03/14/2025
 74.55  76.32  74.05  75.93  6,505,900 
03/13/2025
 74.81  76.11  74.20  74.69  8,228,200 
03/12/2025
 73.14  74.14  72.63  73.60  10,858,200 
03/11/2025
 77.63  78.01  75.78  76.87  7,433,500 
03/10/2025
 78.54  79.42  77.06  77.70  12,603,400 
03/07/2025
 86.97  87.15  84.98  85.79  5,278,200 
03/06/2025
 86.55  87.62  86.07  86.64  5,450,900 
03/05/2025
 90.05  90.44  88.86  89.42  8,011,700 
03/04/2025
 86.90  87.24  84.96  86.11  5,203,600 
03/03/2025
 89.22  89.30  87.59  87.95  4,810,900 
02/28/2025
 88.43  89.28  87.96  89.21  5,962,500 
02/27/2025
 87.54  88.76  87.50  87.81  6,953,800 
02/26/2025
 89.59  89.67  87.86  88.13  7,387,800 
02/25/2025
 90.82  92.31  87.59  89.51  11,465,900 
02/24/2025
 87.45  89.67  86.72  89.15  10,476,300 
02/21/2025
 86.99  87.81  84.38  86.68  15,128,800 
02/20/2025
 81.61  82.67  81.40  82.41  5,015,200 
02/19/2025
 81.62  82.30  81.25  82.08  5,948,100 
02/18/2025
 80.80  81.37  79.77  81.02  8,712,100 
02/14/2025
 77.33  77.82  76.59  76.64  9,875,500 
02/13/2025
 78.28  78.87  77.45  77.58  10,809,200 
02/12/2025
 79.73  81.05  79.25  80.49  6,427,400 
02/11/2025
 82.19  82.91  81.56  82.41  5,046,800 
02/10/2025
 84.34  84.56  82.32  82.58  9,555,000 
02/07/2025
 87.28  87.36  84.77  85.05  8,700,800 
02/06/2025
 85.34  87.54  85.30  85.79  10,576,000 
02/05/2025
 85.06  86.03  83.74  84.37  14,099,000 
02/04/2025
 80.33  82.12  79.98  81.31  9,880,700 

About Novo Nordisk Stock history

Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.5 B4.8 B
Net Income Applicable To Common Shares63.9 B67 B

Novo Nordisk Stock Technical Analysis

Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novo Nordisk technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novo Nordisk trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Novo Nordisk Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.292
Dividend Share
11.4
Earnings Share
3.43
Revenue Per Share
65.202
Quarterly Revenue Growth
0.301
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.